Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Sell
694
-6
-0.9% -$9.55K 0.46% 51
2026
Q1
$925K Buy
700
+28
+4% +$38.4K 0.35% 56
2025
Q4
$719K Sell
672
-8
-1% -$8.35K 0.29% 68
2025
Q3
$658K Hold
680
0.29% 64
2025
Q2
$545K Sell
680
-72
-10% -$51.7K 0.29% 59
2025
Q1
$498K Sell
752
-139
-16% -$101K 0.28% 66
2024
Q4
$618K Buy
891
+151
+20% +$108K 0.34% 59
2024
Q3
$617K Sell
740
-3
-0.4% -$2.68K 0.31% 51
2024
Q2
$760K Buy
743
+45
+6% +$43.3K 0.37% 44
2024
Q1
$677K Buy
698
+56
+9% +$49.7K 0.31% 45
2023
Q4
$486K Buy
+642
New +$424K 0.24% 61

Other funds holding ASML

Traveka Wealth's ASML Position: Q2 2026 in Review

Traveka Wealth reduced its ASML (ASML) stake by 0.86% in Q2 2026, selling an estimated $9.55K and leaving 694 shares worth $1.38M. The position accounts for 0.46% of the portfolio, ranked #51.

Traveka Wealth first reported a position in ASML in Q4 2023 and has held it in 11 quarters since. 1,185 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Traveka Wealth held 694 shares of ASML worth $1.38M as of Q2 2026.
  • Traveka Wealth sold 6 ASML shares in Q2 2026, an estimated $9.55K.
  • ASML made up 0.46% of Traveka Wealth's portfolio in Q2 2026, its #51 holding.
  • Traveka Wealth first reported a position in ASML in Q4 2023 and has held it in 11 quarters since.
  • 1,185 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.